Animal Study with EBV Peptide Microarray
In a study involving 329 specimens, researchers validated a peptide microarray targeting nine EBV proteins. They found broad EBV humoral reactivity in individuals with infectious mononucleosis (IM), multiple sclerosis (MS), and non-MS donors. Notably, they replicated patterns of EBNA-1 C-terminal reactivity associated with MS but determined that overall EBV reactivity does not provide a clear signal to distinguish MS from non-MS samples.